Journal
TRENDS IN NEUROSCIENCES
Volume 37, Issue 7, Pages 388-398Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tins.2014.04.003
Keywords
-
Categories
Funding
- Alzheimer Society of Canada
- Michael Smith Foundation for Health Research
- Canadian Institute for Health Research [97857]
Ask authors/readers for more resources
Loss-of-function mutations in the progranulin gene are a common cause of familial frontotemporal dementia (FTD). The purpose of this review is to summarize the role of progranulin in health and disease, because the field is now poised to begin examining therapeutics that alter endogenous progranulin levels. We first review the clinical and neuropathological phenotype of FTD patients carrying mutations in the progranulin gene, which suggests that progranulin-mediated neurodegeneration is multifactorial and influenced by other genetic and/or environmental factors. We then examine evidence for the role of progranulin in the brain with a focus on mouse model systems. A better understanding of the complexity of progranulin biology in the brain will help guide the development of progranulin-modulating therapies for neurodegenerative disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available